TYK2 as a novel therapeutic target in Alzheimer’s Disease with TDP-43 inclusions.
Laura E. König, Steve Rodriguez, Clemens Hug, Shayda Daneshvari, Alexander Chung, Gary A. Bradshaw, Asli Sahin, George Zhou, Robyn J. Eisert, Federica Piccioni, Sudeshna Das, Marian Kalocsay, Artem Sokolov, Peter Sorger, David E. Root, Mark W. Albers.
Reviewed by: Samelson AJ.
Energetic portrait of the amyloid beta nucleation transition state.
Arutyunyan A, Seuma M, Faure AJ, Bolognesi B, Lehner B.
Reviewed by: Samelson AJ, Fraser JS.